Literature DB >> 6643330

Susceptibility of clostridia from farm animals to 21 antimicrobial agents including some used for growth promotion.

G N Dutta, L A Devriese, P F Van Assche.   

Abstract

The minimal inhibitory concentrations of 21 antimicrobial agents were determined by an agar dilution method against 68 strains of 18 Clostridium species isolated from caeca of pigs, cattle and poultry. Of the therapeutically used antibiotics, chloramphenicol was most active in vitro followed by penicillin G, the lincosamides and tetracycline. Penicillin-resistant Cl. butyricum strains produced a beta-lactamase. Avoparcin, carbadox, monensin, nitrovin and virginiamycin were the most effective of the growth promoting antimicrobial agents. Many clostridial species were naturally resistant to flavomycin and Cl. sporogenes was naturally resistant additionally to bacitracin, tiamulin, the lincosamides and virginiamycin component M. The macrolide, lincosamide and streptogramin resistant strains showed four different patterns of resistance to the antibiotics. One of these resistance patterns was the natural resistance of Cl. sporogenes to the lincosamides and virginiamycin component M which is a streptogramin group A antibiotic.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6643330     DOI: 10.1093/jac/12.4.347

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  2 in total

Review 1.  Antimicrobial growth promoters used in animal feed: effects of less well known antibiotics on gram-positive bacteria.

Authors:  Patrick Butaye; Luc A Devriese; Freddy Haesebrouck
Journal:  Clin Microbiol Rev       Date:  2003-04       Impact factor: 26.132

2.  A possible role for Clostridium difficile in the etiology of calf enteritis.

Authors:  Melissa C Hammitt; Dawn M Bueschel; M Kevin Keel; Robert D Glock; Peder Cuneo; Donald W DeYoung; Carlos Reggiardo; Hien T Trinh; J Glenn Songer
Journal:  Vet Microbiol       Date:  2007-09-18       Impact factor: 3.293

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.